BRIEF published on 10/28/2025 at 19:05, 10 months 14 days ago Rapport de transactions sur actions propres par DEKUPLE Actions Propres Transactions Financières Marché XPAR DÉKUPLE Couverture Salariale
BRIEF published on 10/28/2025 at 19:05, 10 months 14 days ago DEKUPLE Share Transactions Report Financial Transactions Own Shares XPAR Market DÉKUPLE Salary Coverage
PRESS RELEASE published on 10/28/2025 at 19:00, 10 months 14 days ago DÉCLARATION DES TRANSACTIONS SUR ACTIONS PROPRES PÉRIODE DU 20 AU 24 OCTOBRE 2025 Déclaration des transactions sur actions propres réalisées par DEKUPLE du 20 au 24 octobre 2025 Actions Propres Transactions Natixis Rachat DÉKUPLE
BRIEF published on 10/20/2025 at 19:05, 10 months 22 days ago ADLP Partner : Transactions sur Actions Propres du 13 au 17 octobre 2025 Actions Propres Transactions Natixis Couverture Salariale ADLP Partner
BRIEF published on 10/20/2025 at 19:05, 10 months 22 days ago ADLP Partner: Transactions on Own Shares from October 13 to 17, 2025 Transactions Natixis Own Shares Salary Coverage ADLP Partner
PRESS RELEASE published on 10/20/2025 at 19:00, 10 months 22 days ago DÉCLARATION DES TRANSACTIONS SUR ACTIONS PROPRES PÉRIODE DU 13 AU 17 OCTOBRE 2025 Déclaration des transactions sur actions propres réalisées par DEKUPLE du 13 au 17 octobre 2025. Prix pondéré moyen de 25,1294 EUR Actions Propres Transactions Prix Pondéré DÉKUPLE Octobre 2025
BRIEF published on 10/14/2025 at 19:05, 10 months 28 days ago Transactions sur actions propres de DEKUPLE du 6 au 10 octobre 2025 Natixis Transactions Boursières Achat D'actions Marché De Paris Actions DEKUPLE
BRIEF published on 10/14/2025 at 19:05, 10 months 28 days ago DEKUPLE own share transactions from October 6 to 10, 2025 Natixis Purchase Of Shares Stock Market Transactions Paris Market DEKUPLE Actions
PRESS RELEASE published on 10/14/2025 at 19:00, 10 months 28 days ago DÉCLARATION DES TRANSACTIONS SUR ACTIONS PROPRES PÉRIODE DU 6 AU 10 OCTOBRE 2025 Déclaration des transactions sur actions propres du 6 au 10 octobre 2025 pour DEKUPLE avec un volume total de 728 actions et un prix pondéré moyen de 25,1055 EUR Actions Propres Transactions Prix Pondéré Moyen DÉKUPLE Octobre 2025
BRIEF published on 10/07/2025 at 19:24, 11 months 4 days ago Transactions de Rachat d'Actions Propres par DEKUPLE Actions Propres Natixis Prix Moyen D'acquisition DÉKUPLE Transactions Octobre 2025
Published on 09/12/2026 at 02:35, 11 hours 49 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 24 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 19 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 59 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 24 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 54 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 16 hours 9 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 16 hours 14 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 40 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 20 hours 9 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
